Abercrombie HC, Kalin NH, Davidson RJ (2005). Acute cortisol elevations cause heightened arousal ratings of objectively nonarousing stimuli. Emotion 5, 354–359.
Abercrombie HC, Kalin NH, Thurow ME, Rosenkranz MA, Davidson RJ (2003). Cortisol variation in humans affects memory for emotionally laden and neutral information. Behavioral Neuroscience 117, 505–516.
Alfarez DN, De Simoni A, Velzing EH, Bracey E, Joels M, Edwards FA, Krugers HJ (2009). Corticosterone reduces dendritic complexity in developing hippocampal CA1 neurons. Hippocampus 19, 828–836.
Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM (2004). Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. Journal of Clinical Investigation 114, 1146–1157.
Almeida OP, Burton EJ, Ferrier N, McKeith IG, O'Brien JT (2003). Depression with late onset is associated with right frontal lobe atrophy. Psychological Medicine 33, 675–681.
Alt SR, Turner JD, Klok MD, Meijer OC, Lakke EA, Derijk RH, Muller CP (2010). Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 35, 544–556.
Anacker C, Zunszain PA, Cattaneo A, Carvalho LA, Garabedian MJ, Thuret S, Price J, Pariante CM (2011). Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Molecular Psychiatry 16, 738–750.
Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. Journal of Endocrinology 160, 1–12.
Asnis GM, Halbreich U, Nathan RS, Ostrow L, Novacenko H, Endicott J, Sachar EJ (1982). The dexamethasone suppression test in depressive illness: clinical correlates. Psychoneuroendocrinology 7, 295–301.
Bao AM, Swaab DF (2010). Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus. Vitamins and Hormones 82, 339–365.
Beishuizen A, Thijs LG, Vermes I (2002). Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Critical Care 6, 434–438.
Belanoff JK, Flores BH, Kalezhan M, Sund B, Schatzberg AF (2001). Rapid reversal of psychotic depression using mifepristone. Journal of Clinical Psychopharmacology 21, 516–521.
Belay H, Burton CL, Lovic V, Meaney MJ, Sokolowski M, Fleming AS (2011). Early adversity and serotonin transporter genotype interact with hippocampal glucocorticoid receptor mRNA expression, corticosterone, and behavior in adult male rats. Behavioral Neuroscience 125, 150–160.
Bhagwagar Z, Hafizi S, Cowen PJ (2005). Increased salivary cortisol after waking in depression. Psychopharmacology (Berlin) 182, 54–57.
Binder EB, Nemeroff CB (2010). The CRF system, stress, depression and anxiety – insights from human genetic studies. Molecular Psychiatry 15, 574–588.
Birkenhager TK, van den Broek WW, Moleman P, Bruijn JA (2006). Outcome of a 4-step treatment algorithm for depressed inpatients. Journal of Clinical Psychiatry 67, 1266–1271.
Blauer KL, Poth M, Rogers WM, Bernton EW (1991). Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129, 3174–3179.
Blugeot A, Rivat C, Bouvier E, Molet J, Mouchard A, Zeau B, Bernard C, Benoliel JJ, Becker C (2011). Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. Journal of Neuroscience 31, 12889–12899.
Bremner JD, Vythilingam M, Vermetten E, Anderson G, Newcomer JW, Charney DS (2004). Effects of glucocorticoids on declarative memory function in major depression. Biological Psychiatry 55, 811–815.
Bridges PK, Jones MT (1966). The diurnal rhythm of plasma cortisol concentration in depression. British Journal of Psychiatry 112, 1257–1261.
Britton DR, Koob GF, Rivier J, Vale W (1982). Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sciences 31, 363–367.
Brown ES (2009). Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Annals of the New York Academy of Sciences 1179, 41–55.
Brown ES, Denniston D, Gabrielson B, Khan DA, Khanani S, Desai S (2010). Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts. Allergy and Asthma Proceedings 31, 331–336.
Brown G (1986). Expressed emotion and life events in schizophrenia and depression. Journal of Psychosocial Nursing and Mental Health Services 24, 31–34.
Brown GW, Bifulco A, Harris TO (1987). Life events, vulnerability and onset of depression: some refinements. British Journal of Psychiatry 150, 30–42.
Brown WA, Shuey I (1980). Response to dexamethasone and subtype of depression. Archives of General Psychiatry 37, 747–751.
Buchanan TW, Lovallo WR (2001). Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 26, 307–317.
Buford TW, Willoughby DS (2008). Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Applied Physiology, Nutrition, and Metabolism 33, 429–433.
Bukh JD, Bock C, Vinberg M, Werge T, Gether U, Vedel Kessing L (2009). Interaction between genetic polymorphisms and stressful life events in first episode depression. Journal of Affective Disorders 119, 107–115.
Butler PW, Besser GM (1968). Pituitary-adrenal function in depression. Lancet 2, 51.
Cao-Lei L, Leija SC, Kumsta R, Wust S, Meyer J, Turner JD, Muller CP (2011). Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions. Human Genetics 129, 533–543.
Capuron L, Dantzer R (2003). Cytokines and depression: the need for a new paradigm. Brain, Behavior, and Immunology 17 (Suppl. 1), S119–S124.
Carroll BJ (1982). Use of the dexamethasone suppression test in depression. Journal of Clinical Psychiatry 43, 44–50.
Carroll BJ (1986). Informed use of the dexamethasone suppression test. Journal of Clinical Psychiatry 47, 10–12.
Carroll BJ, Martin FI, Davies B (1968). Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. British Medical Journal 3, 285–287.
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003). Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386–389.
Castren E, Rantamaki T (2010). Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 24, 1–7.
Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50, 260–265.
Chen J, Johnson RW (2004). Dehydroepiandrosterone-sulfate did not mitigate sickness behavior in mice. Physiology and Behavior 82, 713–719.
Chen MC, Joormann J, Hallmayer J, Gotlib IH (2009). Serotonin transporter polymorphism predicts waking cortisol in young girls. Psychoneuroendocrinology 34, 681–686.
Christian KM, Miracle AD, Wellman CL, Nakazawa K (2010). Chronic stress-induced hippocampal dendritic retraction requires CA3 NMDA receptors. Neuroscience 174, 26–36.
Chu JW, Matthias DF, Belanoff J, Schatzberg A, Hoffman AR, Feldman D (2001). Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). Journal of Clinical Endocrinology and Metabolism 86, 3568–7353.
Clark JA, Flick RB, Pai LY, Szalayova I, Key S, Conley RK, Deutch AY, Hutson PH, Mezey E (2008). Glucocorticoid modulation of tryptophan hydroxylase-2 protein in raphe nuclei and 5-hydroxytryptophan concentrations in frontal cortex of C57/Bl6 mice. Molecular Psychiatry 13, 498–506.
Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G (1984). A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biological Psychiatry 19, 1215–1228.
Clow A, Thorn L, Evans P, Hucklebridge F (2004). The awakening cortisol response: methodological issues and significance. Stress 7, 29–37.
Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, Pooley JR, Kershaw YM, Meijer OC, De Kloet ER, Lightman SL (2010). Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. Journal of Neuroendocrinology 22, 1093–1100.
Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ (2012). Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biological Psychiatry 71, 15–21.
Dantzer R (2009). Cytokine, sickness behavior, and depression. Immunology and Allergy Clinics of North America 29, 247–264.
Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46–56.
Dantzer R, O'Connor JC, Lawson MA, Kelley KW (2011). Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36, 426–436.
Dedovic K, Engert V, Duchesne A, Lue SD, Andrews J, Efanov SI, Beaudry T, Pruessner JC (2010). Cortisol awakening response and hippocampal volume: vulnerability for major depressive disorder? Biological Psychiatry 68, 847–853.
de Kloet ER, Derijk RH, Meijer OC (2007). Therapy insight: is there an imbalanced response of mineralocorticoid and glucocorticoid receptors in depression? Nature Clinical Practice Endocrinology and Metabolism 3, 168–179.
de Kloet ER, Van Acker SA, Sibug RM, Oitzl MS, Meijer OC, Rahmouni K, de Jong W (2000). Brain mineralocorticoid receptors and centrally regulated functions. Kidney International 57, 1329–1336.
DeRijk RH, de Kloet ER, Zitman FG, van Leeuwen N (2011). Mineralocorticoid receptor gene variants as determinants of HPA axis regulation and behavior. Endocrine Development 20, 137–148.
Deuschle M, Schweiger U, Weber B, Gotthardt U, Korner A, Schmider J, Standhardt H, Lammers CH, Heuser I (1997). Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. Journal of Clinical Endocrinology and Metabolism 82, 234–238.
Dinan TG, Lavelle E, Cooney J, Burnett F, Scott L, Dash A, Thakore J, Berti C (1997). Dexamethasone augmentation in treatment-resistant depression. Acta Psychiatrica Scandinavia 95, 58–61.
Dong HW, Swanson LW, Chen L, Fanselow MS, Toga AW (2009). Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1. Proceedings of the National Academy of Sciences USA 106, 11794–11799.
Dougherty LR, Klein DN, Olino TM, Dyson M, Rose S (2009). Increased waking salivary cortisol and depression risk in preschoolers: the role of maternal history of melancholic depression and early child temperament. Journal of Child Psychology and Psychiatry 50, 1495–1503.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry 67, 446–457.
Duman RS, Malberg J, Thome J (1999). Neural plasticity to stress and antidepressant treatment. Biological Psychiatry 46, 1181–1191.
Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
Engert V, Efanov SI, Dedovic K, Dagher A, Pruessner JC (2011). Increased cortisol awakening response and afternoon/evening cortisol output in healthy young adults with low early life parental care. Psychopharmacology (Berlin) 214, 261–268.
Engert V, Efanov SI, Dedovic K, Duchesne A, Dagher A, Pruessner JC (2010). Perceived early-life maternal care and the cortisol response to repeated psychosocial stress. Journal of Psychiatry and Neuroscience 35, 370–377.
Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998). Neurogenesis in the adult human hippocampus. Nature Medicine 4, 1313–1317.
Feldman D, Mondon CE, Horner JA, Weiser JN (1979). Glucocorticoid and estrogen regulation of corticosteroid-binding globulin production by rat liver. Americal Journal of Physiology 237, E493–E499.
Flammer JR, Rogatsky I (2011). Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms. Molecular Endocrinology 25, 1075–1086.
Flores BH, Kenna H, Keller J, Solvason HB, Schatzberg AF (2006). Clinical and biological effects of mifepristone treatment for psychotic depression. Neuropsychopharmacology 31, 628–636.
Franz CE, O'Brien RC, Hauger RL, Mendoza SP, Panizzon MS, Prom-Wormley E, Eaves LJ, Jacobson K, Lyons MJ, Lupien S, Hellhammer D, Xian H, Kremen WS (2011). Cross-sectional and 35-year longitudinal assessment of salivary cortisol and cognitive functioning: the Vietnam Era twin study of aging. Psychoneuroendocrinology 36, 1040–1052.
Gadek-Michalska A, Bugajski AJ, Bugajski J (2008). Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions. Journal of Physiology and Pharmacology 59, 563–575.
Garcia-Bueno B, Caso JR, Leza JC (2008). Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neuroscience and Biobehavioral Reviews 32, 1136–1151.
Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM (2009). Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Molecular Psychiatry 14, 681–695.
Gemma C, Bachstetter AD, Cole MJ, Fister M, Hudson C, Bickford PC (2007). Blockade of caspase-1 increases neurogenesis in the aged hippocampus. European Journal of Neuroscience 26, 2795–2803.
Gerritsen L, Geerlings MI, Bremmer MA, Beekman AT, Deeg DJ, Penninx BW, Comijs HC (2009). Personality characteristics and hypothalamic-pituitary-adrenal axis regulation in older persons. American Journal of Geriatric Psychiatry 17, 1077–1084.
Gilhooley MJ, Pinnock SB, Herbert J (2011). Rhythmic expression of per1 in the dentate gyrus is suppressed by corticosterone: implications for neurogenesis. Neuroscience Letters 489, 177–181.
Glover V, O'Connor TG, O'Donnell K (2010). Prenatal stress and the programming of the HPA axis. Neuroscience and Biobehavioral Reviews 35, 17–22.
Goodwin GM, Muir WJ, Seckl JR, Bennie J, Carroll S, Dick H, Fink G (1992). The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls. Journal of Affective Disorders 26, 73–83.
Goodyer IM, Bacon A, Ban M, Croudace T, Herbert J (2009). Serotonin transporter genotype, morning cortisol and subsequent depression in adolescents. British Journal of Psychiatry 195, 39–45.
Goodyer IM, Croudace T, Dudbridge F, Ban M, Herbert J (2010). Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. British Journal of Psychiatry 197, 365–371.
Goodyer IM, Herbert J, Tamplin A (2003). Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychological Medicine 33, 601–610.
Goodyer IM, Herbert J, Tamplin A, Altham PM (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. British Journal of Psychiatry 177, 499–504.
Groves JO (2007). Is it time to reassess the BDNF hypothesis of depression? Molecular Psychiatry 12, 1079–1088.
Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J (1996). Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. Journal of Clinical Endocrinology and Metabolism 81, 3951–3960.
Gubba EM, Netherton CM, Herbert J (2000). Endangerment of the brain by glucocorticoids: experimental and clinical evidence. Journal of Neurocytology 29, 439–449.
Gutierrez-Mecinas M, Trollope AF, Collins A, Morfett H, Hesketh SA, Kersante F, Reul JM (2011). Long-lasting behavioral responses to stress involve a direct interaction of glucocorticoid receptors with ERK1/2-MSK1-Elk-1 signaling. Proceedings of the National Academy of Sciences USA 108, 13806–13811.
Hainer V, Kunesova M, Stunkard AJ, Parizkova J, Stich V, Mikulova R, Starka L (2001). The within-pair resemblance in serum levels of androgens, sex-hormone binding globulin and cortisol in female obese identical twins – effect of negative energy balance induced by very low-calorie diet. Hormone and Metabolic Research 33, 417–422.
Halligan SL, Herbert J, Goodyer IM, Murray L (2004). Exposure to postnatal depression predicts elevated cortisol in adolescent offspring. Biological Psychiatry 55, 376–381.
Harris TO, Borsanyi S, Messari S, Stanford K, Cleary SE, Shiers HM, Brown GW, Herbert J (2000). Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. British Journal of Psychiatry 177, 505–510.
Hasler BP, Buysse DJ, Kupfer DJ, Germain A (2010). Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression. Psychiatry Research 178, 205–207.
Hastings MH, Maywood ES, Reddy AB (2008). Two decades of circadian time. Journal of Neuroendocrinology 20, 812–819.
Hazra A, DuBois DC, Almon RR, Jusko WJ (2007). Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling. Journal of Pharmacokinetics and Pharmacodynamics 34, 333–354.
Herbert J (1993). Peptides in the limbic system: neurochemical codes for co-ordinated adaptive responses to behavioural and physiological demand. Progress in Neurobiology 41, 723–791.
Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR (2006). Do corticosteroids damage the brain? Journal of Neuroendocrinology 18, 393–411.
Het S, Wolf OT (2007). Mood changes in response to psychosocial stress in healthy young women: effects of pretreatment with cortisol. Behavioral Neuroscience 121, 11–20.
Heydendael W, Jacobson L (2009). Glucocorticoid status affects antidepressant regulation of locus coeruleus tyrosine hydroxylase and dorsal raphe tryptophan hydroxylase gene expression. Brain Research 1288, 69–78.
Holsboer F, Grasser A, Friess E, Wiedemann K (1994). Steroid effects on central neurons and implications for psychiatric and neurological disorders. Annals of the New York Academy of Sciences 746, 345–359; discussion 359–361.
Homberg JR, Lesch KP (2011). Looking on the bright side of serotonin transporter gene variation. Biological Psychiatry 69, 513–519.
Huang GJ, Herbert J (2006). Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone. Biological Psychiatry 59, 619–624.
Hucklebridge F, Clow A, Evans P (1998). The relationship between salivary secretory immunoglobulin A and cortisol: neuroendocrine response to awakening and the diurnal cycle. International Journal of Psychophysiology 31, 69–76.
Hunter AL, Minnis H, Wilson P (2011). Altered stress responses in children exposed to early adversity: a systematic review of salivary cortisol studies. Stress 14, 614–626.
Ivy AS, Rex CS, Chen Y, Dube C, Maras PM, Grigoriadis DE, Gall CM, Lynch G, Baram TZ (2010). Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors. Journal of Neuroscience 30, 13005–13015.
Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM (1979). Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. Quarterly Journal of Medicine 48, 465–472.
Joels M, de Kloet ER (1994). Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Progress in Neurobiology 43, 1–36.
Kahl KG, Bens S, Ziegler K, Rudolf S, Dibbelt L, Kordon A, Schweiger U (2006). Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biological Psychiatry 59, 667–671.
Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G (2005). Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biological Psychiatry 57, 1068–1072.
Karishma KK, Herbert J (2002). Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. European Journal of Neuroscience 16, 445–453.
Kathol RG, Jaeckle RS, Lopez JF, Meller WH (1989). Pathophysiology of HPA axis abnormalities in patients with major depression: an update. American Journal of Psychiatry 146, 311–317.
Kaufman J, Yang BZ, Douglas-Palumberi H, Grasso D, Lipschitz D, Houshyar S, Krystal JH, Gelernter J (2006). Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biological Psychiatry 59, 673–680.
Kendler KS, Kuhn JW, Prescott CA (2004). Childhood sexual abuse, stressful life events and risk for major depression in women. Psychological Medicine 34, 1475–1482.
Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS, Lozano AM (2011). Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. American Journal of Psychiatry 168, 502–510.
Khorram O, Vu L, Yen SS (1997). Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 52, M1–M7.
Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J (1998). Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proceedings of the National Academy of Sciences USA 95, 1852–1857.
Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ (2004). 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. Journal of Psychiatric Research 38, 503–511.
Kohler S, Thomas AJ, Lloyd A, Barber R, Almeida OP, O'Brien JT (2010). White matter hyperintensities, cortisol levels, brain atrophy and continuing cognitive deficits in late-life depression. British Journal of Psychiatry 196, 143–149.
Kunugi H, Hori H, Adachi N, Numakawa T (2010). Interface between hypothalamic-pituitary-adrenal axis and brain-derived neurotrophic factor in depression. Psychiatry and Clinical Neuroscience 64, 447–459.
Langenecker SA, Weisenbach SL, Giordani B, Briceno EM, Guidotti Breting LM, Schallmo MP, Leon HM, Noll DC, Zubieta JK, Schteingart DE, Starkman MN (2012). Impact of chronic hypercortisolemia on affective processing. Neuropharmacology 62, 217–225.
Lenczowski MJ, Bluthe RM, Roth J, Rees GS, Rushforth DA, van Dam AM, Tilders FJ, Dantzer R, Rothwell NJ, Luheshi GN (1999). Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. American Journal of Physiology 276, R652–R658.
Lewis DA, Smith RE (1983). Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. Journal of Affective Disorders 5, 319–332.
Lewis G, Collishaw S, Harold G, Rice F, Thapar A (2012). Maternal depression and child and adolescent depression symptoms: an exploratory test for moderation by CRHR1, FKBP5 and NR3C1 gene variants. Behavioral Genetics 42, 121–132.
Lightman SL, Conway-Campbell BL (2010). The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nature Reviews Neuroscience 11, 710–718.
Lightman SL, Wiles CC, Atkinson HC, Henley DE, Russell GM, Leendertz JA, McKenna MA, Spiga F, Wood SA, Conway-Campbell BL (2008). The significance of glucocorticoid pulsatility. European Journal of Pharmacology 583, 255–262.
Liston C, Gan WB (2011). Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proceedings of the National Academy of Sciences USA 108, 16074–16079.
Luby JL, Heffelfinger A, Mrakotsky C, Brown K, Hessler M, Spitznagel E (2003). Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Archives of General Psychiatry 60, 1248–1255.
Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009). Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nature Reviews Neuroscience 10, 434–445.
Maes M (2011). Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 35, 664–675.
Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011). The new ‘5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 35, 702–721.
Magarinos AM, McEwen BS (1995). Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69, 89–98.
Malberg JE (2004). Implications of adult hippocampal neurogenesis in antidepressant action. Journal of Psychiatry and Neuroscience 29, 196–205.
Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience 20, 9104–9110.
Mannie ZN, Harmer CJ, Cowen PJ (2007). Increased waking salivary cortisol levels in young people at familial risk of depression. American Journal of Psychiatry 164, 617–621.
Markopoulou K, Papadopoulos A, Juruena MF, Poon L, Pariante CM, Cleare AJ (2009). The ratio of cortisol/DHEA in treatment resistant depression. Psychoneuroendocrinology 34, 19–26.
Masters JN, Finch CE, Sapolsky RM (1989). Glucocorticoid endangerment of hippocampal neurons does not involve deoxyribonucleic acid cleavage. Endocrinology 124, 3083–3088.
May M, Holmes E, Rogers W, Poth M (1990). Protection from glucocorticoid induced thymic involution by dehydroepiandrosterone. Life Sciences 46, 1627–1631.
Maya Vetencourt JF, Sale A, Viegi A, Baroncelli L, De Pasquale R, O'Leary OF, Castren E, Maffei L (2008). The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320, 385–388.
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, Schwalb JM, Kennedy SH (2005). Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–660.
Mayer EA, Baldi JP (1991). Can regulatory peptides be regarded as words of a biological language. American Journal of Physiology 261, G171–G184.
Maywood ES, O'Neill J, Wong GK, Reddy AB, Hastings MH (2006). Circadian timing in health and disease. Progress in Brain Research 153, 253–269.
Maywood ES, O'Neill JS, Reddy AB, Chesham JE, Prosser HM, Kyriacou CP, Godinho SI, Nolan PM, Hastings MH (2007). Genetic and molecular analysis of the central and peripheral circadian clockwork of mice. Cold Spring Harbor Symposia in Quantitative Biology 72, 85–94.
McGowan PO, Suderman M, Sasaki A, Huang TC, Hallett M, Meaney MJ, Szyf M (2011). Broad epigenetic signature of maternal care in the brain of adult rats. PLoS ONE 6, e14739.
McLaughlin KA, Nolen-Hoeksema S (2011). Rumination as a transdiagnostic factor in depression and anxiety. Behavioral Research and Therapy 49, 186–193.
McMaster A, Jangani M, Sommer P, Han N, Brass A, Beesley S, Lu W, Berry A, Loudon A, Donn R, Ray DW (2011). Ultradian cortisol pulsatility encodes a distinct, biologically important signal. PLoS ONE 6, e15766.
Meaney MJ, Szyf M (2005). Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues in Clinical Neuroscience 7, 103–123.
Menet JS, Rosbash M (2011). When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders. Current Opinion in Neurobiology 21, 1–9.
Merz CJ, Tabbert K, Schweckendiek J, Klucken T, Vaitl D, Stark R, Wolf OT (2010). Investigating the impact of sex and cortisol on implicit fear conditioning with fMRI. Psychoneuroendocrinology 35, 33–46.
Michael A, Jenaway A, Paykel ES, Herbert J (2000). Altered salivary dehydroepiandrosterone levels in major depression in adults. Biological Psychiatry 48, 989–995.
Mullen PE, Linsell CR, Parker D (1986). Influence of sleep disruption and calorie restriction on biological markers for depression. Lancet 2, 1051–1055.
Nater UM, Hoppmann C, Klumb PL (2010). Neuroticism and conscientiousness are associated with cortisol diurnal profiles in adults – role of positive and negative affect. Psychoneuroendocrinology 35, 1573–1577.
Nederhof E, Bouma EM, Oldehinkel AJ, Ormel J (2010). Interaction between childhood adversity, brain-derived neurotrophic factor val/met and serotonin transporter promoter polymorphism on depression: the TRAILS study. Biological Psychiatry 68, 209–212.
Netherton C, Goodyer I, Tamplin A, Herbert J (2004). Salivary cortisol and dehydroepiandrosterone in relation to puberty and gender. Psychoneuroendocrinology 29, 125–140.
Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL (1999). Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Archives of General Psychiatry 56, 527–533.
Nishi M, Noriko HH, Kawata M (2011). Intranuclear dynamics of corticosteroid receptors and effects of proteasomal activity in cultured hippocampal neural cells. Neuroscience Letters 494, 65–69.
Nolen-Hoeksema S, Wisco EE, Lynubomirsky S (2011). Rethinking rumination. Perpectives on Psychological Science 3, 400–424.
Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM (2008). Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3, 97–106.
O'Brien JT, Lloyd A, McKeith I, Gholkar A, Ferrier N (2004). A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. American Journal of Psychology 161, 2081–2090.
O'Regan D, Welberg LL, Holmes MC, Seckl JR (2001). Glucocorticoid programming of pituitary-adrenal function: mechanisms and physiological consequences. Seminars in Neonatology 6, 319–329.
Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. Journal of Clinical Endocrinology and Metabolism 59, 551–555.
Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H (1992). Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. Journal of Clinical Endocrinology and Metabolism 75, 1002–1004.
Otte C, Marmar CR, Pipkin SS, Moos R, Browner WS, Whooley MA (2004). Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: the Heart and Soul Study. Biological Psychiatry 56, 241–247.
Ouellet-Morin I, Boivin M, Dionne G, Lupien SJ, Arseneault L, Barr RG, Perusse D, Tremblay RE (2008). Variations in heritability of cortisol reactivity to stress as a function of early familial adversity among 19-month-old twins. Archives of General Psychiatry 65, 211–218.
Oxenkrug GF (2010). Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Israeli Journal of Psychiatry and Related Sciences 47, 56–63.
Pace TW, Miller AH (2009). Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Annals of the New York Academy of Sciences 1179, 86–105.
Parker GB, Brown LB (1982). Coping behaviors that mediate between life events and depression. Archives of General Psychiatry 39, 1386–1391.
Pereira AM, Tiemensma J, Romijn JA (2010). Neuropsychiatric disorders in Cushing's syndrome. Neuroendocrinology 92 (Suppl. 1), 65–70.
Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience 8, 828–834.
Pfohl B, Sherman B, Schlechte J, Stone R (1985). Pituitary-adrenal axis rhythm disturbances in psychiatric depression. Archives of General Psychiatry 42, 897–903.
Pinnock SB, Balendra R, Chan M, Hunt LT, Turner-Stokes T, Herbert J (2007). Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropsychopharmacology 32, 493–504.
Pinnock SB, Blake AM, Platt NJ, Herbert J (2010). The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine. PLoS ONE 5, e13652.
Piser TM (2010). Linking the cytokine and neurocircuitry hypotheses of depression: a translational framework for discovery and development of novel anti-depressants. Brain, Behavior, and Immunology 24, 515–524.
Portella MJ, Harmer CJ, Flint J, Cowen P, Goodwin GM (2005). Enhanced early morning salivary cortisol in neuroticism. American Journal of Psychiatry 162, 807–809.
Prickaerts J, van den Hove DL, Fierens FL, Kia HK, Lenaerts I, Steckler T (2006). Chronic corticosterone manipulations in mice affect brain cell proliferation rates, but only partly affect BDNF protein levels. Neuroscience Letters 396, 12–16.
Qureshi AC, Bahri A, Breen LA, Barnes SC, Powrie JK, Thomas SM, Carroll PV (2007). The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clinical Endocrinology (Oxford) 66, 632–635.
Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ, Ferrando SJ (2006). Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. American Journal of Psychiatry 163, 59–66.
Reisch N, Arlt W (2009). Fine tuning for quality of life: 21st century approach to treatment of Addison's disease. Endocrinology and Metabolism Clinics of North America 38, 407–418, ix–x.
Reul JM, Gesing A, Droste S, Stec IS, Weber A, Bachmann C, Bilang-Bleuel A, Holsboer F, Linthorst AC (2000). The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. European Journal of Pharmacology 405, 235–249.
Roozendaal B, McEwen BS, Chattarji S (2009). Stress, memory and the amygdala. Nature Reviews Neuroscience 10, 423–433.
Rosenfeld P, van Eekelen JA, Levine S, de Kloet ER (1993). Ontogeny of corticosteroid receptors in the brain. Cellular and Molecular Neurobiology 13, 295–319.
Roskoden T, Otten U, Schwegler H (2004). Early postnatal corticosterone administration regulates neurotrophins and their receptors in septum and hippocampus of the rat. Experimental Brain Research 154, 183–191.
Rubin RT, Phillips JJ, Sadow TF, McCracken JT (1995). Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Archives of General Psychiatry 52, 213–218.
Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR Jr., Weissenburger JE, Crowley GT, Khatami M, Vasavada N (1996). The dexamethasone suppression test in patients with mood disorders. Journal of Clinical Psychiatry 57, 470–484.
Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF (1973). Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Archives of General Psychiatry 28, 19–24.
Sairanen M, Lucas G, Ernfors P, Castren M, Castren E (2005). Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. Journal of Neuroscience 25, 1089–1094.
Salomon S, Bejar C, Schorer-Apelbaum D, Weinstock M (2011). Corticosterone mediates some but not other behavioural changes induced by prenatal stress in rats. Journal of Neuroendocrinology 23, 118–128.
Santos GM, Fairall L, Schwabe JW (2011). Negative regulation by nuclear receptors: a plethora of mechanisms. Trends in Endocrinology and Metabolism 22, 87–93.
Sartorius A, Henn FA (2007). Deep brain stimulation of the lateral habenula in treatment resistant major depression. Medical Hypotheses 69, 1305–1308.
Schaaf MJ, de Jong J, de Kloet ER, Vreugdenhil E (1998). Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Research 813, 112–120.
Schaaf MJ, Hoetelmans RW, de Kloet ER, Vreugdenhil E (1997). Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. Journal of Neuroscience Research 48, 334–341.
Schlesser MA, Winokur G, Sherman BM (1980). Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. Archives of General Psychiatry 37, 737–743.
Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR (2005). Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Archives of General Psychiatry 62, 154–162.
Schommer NC, Kudielka BM, Hellhammer DH, Kirschbaum C (1999). No evidence for a close relationship between personality traits and circadian cortisol rhythm or a single cortisol stress response. Psychological Reports 84, 840–842.
Schulkin J (2011). Evolutionary conservation of glucocorticoids and corticotropin releasing hormone: behavioral and physiological adaptations. Brain Research 1392, 27–46.
Seckl JR, Holmes MC (2007). Mechanisms of disease: glucocorticoids, their placental metabolism and fetal ‘programming’ of adult pathophysiology. Nature Clinical Practice in Endocrinology and Metabolism 3, 479–488.
Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 22, 3251–3261.
Simpson GM, El Sheshai A, Loza N, Kingsbury SJ, Fayek M, Rady A, Fawzy W (2005). An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression. Journal of Clinical Psychiatry 66, 598–602.
Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA (2011). A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nature Reviews Neuroscience 12, 585–601.
Soravia LM, de Quervain DJ, Heinrichs M (2009). Glucocorticoids do not reduce subjective fear in healthy subjects exposed to social stress. Biological Psychology 81, 184–188.
Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U, Roozendaal B, de Quervain DJ (2006). Glucocorticoids reduce phobic fear in humans. Proceedings of the National Academy of Sciences USA 103, 5585–5590.
Srinivasan V, Singh J, Pandi-Perumal SR, Brown GM, Spence DW, Cardinali DP (2010). Jet lag, circadian rhythm sleep disturbances, and depression: the role of melatonin and its analogs. Advances in Therapy 27, 796–813.
Starkman MN, Schteingart DE, Schork MA (1981). Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosomatic Medicine 43, 3–18.
Steckler T (2010). Developing small molecule nonpeptidergic drugs for the treatment of anxiety disorders: is the challenge still ahead? Current Topics in Behavioral Neuroscience 2, 415–428.
Stranahan AM, Arumugam TV, Mattson MP (2011). Lowering corticosterone levels reinstates hippocampal brain-derived neurotropic factor and Trkb expression without influencing deficits in hypothalamic brain-derived neurotropic factor expression in leptin receptor-deficient mice. Neuroendocrinology 93, 58–64.
Strelzyk F, Hermes M, Naumann E, Oitzl M, Walter C, Busch HP, Richter S, Schachinger H (2012). Tune it down to live it up? Rapid, nongenomic effects of cortisol on the human brain. Journal of Neuroscience 32, 616–625.
Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S (2011). Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Blood 118, 4723–4731.
Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ (2005). Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Frontiers in Neuroendocrinology 26, 139–162.
Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM (2010). Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 95, E129–E141.
Tombaugh GC, Yang SH, Swanson RA, Sapolsky RM (1992). Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. Journal of Neurochemistry 59, 137–146.
Turner JD, Alt SR, Cao L, Vernocchi S, Trifonova S, Battello N, Muller CP (2010). Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochemical Pharmacology 80, 1860–1868.
Tyrka AR, Kelly MM, Graber JA, DeRose L, Lee JK, Warren MP, Brooks-Gunn J (2010). Behavioral adjustment in a community sample of boys: links with basal and stress-induced salivary cortisol concentrations. Psychoneuroendocrinology 35, 1167–1177.
Uchida Y, Ohtsuki S, Kamiie J, Terasaki T (2011). Blood-brain barrier (BBB) pharmacoproteomics (PPx): reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice. Journal of Pharmacology and Experimental Therapeutics 339, 579–588.
Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J (1994). Neurotoxicity of glucocorticoids in the primate brain. Hormones and Behavoir 28, 336–348.
van der Meer MJ, Hermus AR, Pesman GJ, Sweep CG (1996). Effects of cytokines on pituitary beta-endorphin and adrenal corticosterone release in vitro. Cytokine 8, 238–247.
van der Vegt EJ, van der Ende J, Huizink AC, Verhulst FC, Tiemeier H (2010). Childhood adversity modifies the relationship between anxiety disorders and cortisol secretion. Biological Psychiatry 68, 1048–1054.
van Rossum EF, Russcher H, Lamberts SW (2005). Genetic polymorphisms and multifactorial diseases: facts and fallacies revealed by the glucocorticoid receptor gene. Trends in Endocrinology and Metabolism 16, 445–450.
van Rossum EF, van den Akker EL (2011). Glucocorticoid resistance. Endocrine Development 20, 127–136.
van Santen A, Vreeburg SA, Van der Does AJ, Spinhoven P, Zitman FG, Penninx BW (2011). Psychological traits and the cortisol awakening response: results from the Netherlands Study of Depression and Anxiety. Psychoneuroendocrinology 36, 240–248.
Veen G, van Vliet IM, DeRijk RH, Giltay EJ, van Pelt J, Zitman FG (2010). Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety. Psychiatry Research 185, 121–128.
Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B (2010). Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Molecular Psychiatry 15, 260–271.
von Zerssen D, Barthelmes H, Dirlich G, Doerr P, Emrich HM, von Lindern L, Lund R, Pirke KM (1985). Circadian rhythms in endogenous depression. Psychiatry Research 16, 51–63.
Vreeburg SA, Hartman CA, Hoogendijk WJ, van Dyck R, Zitman FG, Ormel J, Penninx BW (2010). Parental history of depression or anxiety and the cortisol awakening response. British Journal of Psychiatry 197, 180–185.
Wachtel SR, de Wit H (2001). Lack of effect of intravenous hydrocortisone on mood in humans: a preliminary study. Behavioral Pharmacology 12, 373–376.
Watanabe Y, Gould E, McEwen BS (1992). Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Research 588, 341–345.
White T, Ozel B, Jain JK, Stanczyk FZ (2006). Effects of transdermal and oral contraceptives on estrogen-sensitive hepatic proteins. Contraception 74, 293–296.
Wichers MC, Myin-Germeys I, Jacobs N, Kenis G, Derom C, Vlietinck R, Delespaul P, Mengelers R, Peeters F, Nicolson N, van Os J (2008). Susceptibility to depression expressed as alterations in cortisol day curve: a cross-twin, cross-trait study. Psychosomatic Medicine 70, 314–318.
Wiench M, John S, Baek S, Johnson TA, Sung MH, Escobar T, Simmons CA, Pearce KH, Biddie SC, Sabo PJ, Thurman RE, Stamatoyannopoulos JA, Hager GL (2011). DNA methylation status predicts cell type-specific enhancer activity. EMBO Journal 30, 3028–3039.
Wirth MM, Scherer SM, Hoks RM, Abercrombie HC (2011). The effect of cortisol on emotional responses depends on order of cortisol and placebo administration in a within-subject design. Psychoneuroendocrinology 36, 945–954.
Wirz-Justice A (2006). Biological rhythm disturbances in mood disorders. International Clinical Psychopharmacology 21 (Suppl. 1), S11–S15.
Wolf OT, Convit A, McHugh PF, Kandil E, Thorn EL, De Santi S, McEwen BS, de Leon MJ (2001). Cortisol differentially affects memory in young and elderly men. Behavioral Neuroscience 115, 1002–1011.
Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E (1999). Double-blind treatment of major depression with dehydroepiandrosterone. American Journal of Psychiatry 156, 646–649.
Wong EY, Herbert J (2004). The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus. European Journal of Neuroscience 20, 2491–2498.
Wong EY, Herbert J (2006). Raised circulating corticosterone inhibits neuronal differentiation of progenitor cells in the adult hippocampus. Neuroscience 137, 83–92.
Yang S, Liu A, Weidenhammer A, Cooksey RC, McClain D, Kim MK, Aguilera G, Abel ED, Chung JH (2009). The role of mPer2 clock gene in glucocorticoid and feeding rhythms. Endocrinology 150, 2153–2160.
Young EA, Carlson NE, Brown MB (2001). Twenty-four-hour ACTH and cortisol pulsatility in depressed women. Neuropsychopharmacology 25, 267–276.
Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H (2003). Mineralocorticoid receptor function in major depression. Archives of General Psychiatry 60, 24–28.
Young EA, Nolen-Hoeksema S (2001). Effect of ruminations on the saliva cortisol response to a social stressor. Psychoneuroendocrinology 26, 319–329.
Zamudio SR, Quevedo-Corona L, Garces L, De La Cruz F (2009). The effects of acute stress and acute corticosterone administration on the immobility response in rats. Brain Research Bulletin 80, 331–336.
Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, Uhr M, Lieb R, Moffitt TE, Caspi A, Holsboer F, Ising M (2011). Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. American Journal of Psychiatry 168, 1107–1116.
Zoccola PM, Quas JA, Yim IS (2010). Salivary cortisol responses to a psychosocial laboratory stressor and later verbal recall of the stressor: the role of trait and state rumination. Stress 13, 435–443.
Zunszain PA, Anacker C, Cattaneo A, Choudhury S, Musaelyan K, Myint AM, Thuret S, Price J, Pariante CM (2012). Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 37, 939–949.